Syringe News and Research

RSS

BioHorizons launches MinerOss X for dental implant site development procedures

BioHorizons, an oral reconstructive device company, today announced the launch of MinerOss X, a family of xenograft products for dental implant site development procedures. The MinerOss X family includes cancellous or cortical particulate, a moldable collagen block, and a cancellous particulate pre-loaded into a delivery syringe to assist with optimal placement.

12 Oct 2014

B. Braun to become exclusive U.S. distributor of BSmart injection pressure monitor for PNBs

B. Braun Medical Inc. (B.Braun), the market leader in Regional Anesthesia (RA) announced today that it will become the exclusive U.S. distributor of the BSmart™ injection pressure monitor for peripheral nerve blocks (PNBs) from Concert Medical, LLC.

From B. Braun Melsungen AG 9 Oct 2014

Gerresheimer Q3 revenues up 2.2% to EUR 323.9m

Gerresheimer AG again increased revenues in the third quarter of financial year 2014.

8 Oct 2014

Reducing community transmission is key to containing Ebola outbreaks

Reducing community transmission and changing behaviour in communities is key to containing Ebola outbreaks, according to new research into the first known outbreak of the virus in 1976 by researchers at the London School of Hygiene & Tropical Medicine and Fogarty International Center at the National Institutes of Health.

7 Oct 2014

Osprey Medical to release enhanced AVERT Plus System at TCT Meeting

Osprey Medical Inc. has developed a new smart syringe and LCD display system, soon to be incorporated with its existing AVERT System.

16 Sep 2014

Researchers address major challenge in quest to build replacement kidneys in the lab

Regenerative medicine researchers at Wake Forest Baptist Medical Center have addressed a major challenge in the quest to build replacement kidneys in the lab.

9 Sep 2014

Teens and young adults face high risk from opioid-involved overdose

The prevalence of opioid-involved overdoses has become an increasing concern to health officials both in NYC and nationally.

3 Sep 2014

New vaccine in bid to move away from needles and syringes to skin delivery procedures

Drug delivery technologies that improve access and overall efficacy are becoming an essential part of the entire drug development process.

2 Sep 2014

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly is a chronic, life-threatening disease triggered by a benign tumour of the pituitary gland causing excessive growth hormone release. Oversupply of growth hormone stimulates liver, fat and kidney cells to produce excess levels of Insulin-Like Growth Factor I (IGFI), which causes abnormal growth of the bones of the hands, face and feet and bodily organs.

26 Aug 2014

Viewpoints: Why Emory accepted American Ebola cases; calls for terrified Americans to 'chill out'

Blame it on Richard Preston. "The Hot Zone," his 1994 nonfiction science thriller about the spread and devastation of the Ebola virus, pretty much set the standard for terrifying contagion scenarios. ...

8 Aug 2014

Washington bioengineers discover potential method to protect women from contracting HIV

Soon, protection from HIV infection could be as simple as inserting a medicated, disappearing fabric minutes before having sex.

31 Jul 2014

Biogen Idec receives marketing authorization from EC for multiple sclerosis drug

Today Biogen Idec announced that the European Commission (EC) has granted marketing authorization for PLEGRIDY (peginterferon beta-1a) as a treatment for adults with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).

25 Jul 2014

New guidelines integrate biomedical advances and behavioral interventions for HIV people

In an innovative approach to HIV prevention, an interdisciplinary group of experts has come together for the first time to lay out a framework of best practices to optimize the role of the clinician in achieving an AIDS-free generation.

21 Jul 2014

Failure to provide adequate HIV services threatens global progress on HIV response, warns WHO

Failure to provide adequate HIV services for key groups - men who have sex with men, people in prison, people who inject drugs, sex workers and transgender people - threatens global progress on the HIV response, warns WHO.

11 Jul 2014

Gerresheimer substantially increases earnings in second quarter of financial year 2014

Gerresheimer AG substantially increased earnings in the second quarter of financial year 2014."High-quality packaging for drugs and products enabling safe and easy self-medication continues to be increasingly in demand worldwide.

10 Jul 2014

HIV infection emerges among PWID in the Middle East and North Africa

HIV epidemics are emerging among people who inject drugs in several countries in the Middle East and North Africa. Though HIV infection levels were historically very low in the Middle East and North Africa, substantial levels of HIV transmission and emerging HIV epidemics have been documented among people who inject drugs in at least one-third of the countries of this region, according to findings published today in PLOS Medicine.

20 Jun 2014

American Association of Diabetes Educators suggests tips for safe travel

AAA estimates 36.1 million people will travel this Memorial Day weekend. If diabetes is your constant companion, that doesn't mean you can't enjoy traveling, whether traversing America in an RV or flying to the far reaches of the globe. Ensuring you stay healthy and keep your glucose levels on an even keel does require a little bit of organization and planning ahead, though.

23 May 2014

Auxilium Pharmaceuticals presents new XIAFLEX clinical trial data at AUA Meeting

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that new analyses of data were presented from its clinical program and pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the Phase 3 studies that evaluated XIAFLEX® (collagenase clostridium histolyticum or CCH) for the treatment of Peyronie's disease (PD).

19 May 2014

Convenient new treatment option for rheumatoid arthritis sufferers offers patient freedom and control of disease

A new subcutaneous formulation of RoActemra® (tocilizumab) has today been launched providing thousands of UK rheumatoid arthritis (RA) patients with a potentially life-changing treatment option.1